Related Experiment Video
Updated: Nov 19, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
Satoshi Kutsuna1, Yusuke Asai2, Akihiro Matsunaga3
1Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Insights
Male sex, diabetes, and high C-reactive protein (CRP) levels are linked to higher anti-SARS-CoV-2 antibody levels in COVID-19 patients. Antibody titers peaked 5-6 weeks post-symptom onset.
Area of Science:
- Immunology
- Infectious Diseases
- Virology
Background:
- Factors influencing anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody production in coronavirus disease 2019 (COVID-19) patients are not fully understood.
- Identifying these factors is crucial for understanding immune responses and vaccine efficacy.
Purpose of the Study:
- To investigate factors associated with elevated anti-SARS-CoV-2 antibody titers in convalescing COVID-19 patients.
- To determine the relationship between disease onset and antibody titer development.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to measure anti-SARS-CoV-2 spike protein antibody titers.
- Data from 84 COVID-19 patients, including acute and convalescent phases, were analyzed.
- Multivariate log-normal analysis assessed factors related to antibody levels.
Main Results:
- Antibody titers peaked approximately 5-6 weeks after symptom onset.
- Male sex, diabetes mellitus, and high C-reactive protein (CRP) levels during acute illness were significantly associated with elevated IgG antibody titers (P < 0.05).
- Glucocorticoid use did not show a significant association with antibody titers.
Conclusions:
- High maximum CRP levels during acute COVID-19, male sex, and diabetes mellitus are key factors associated with higher anti-SARS-CoV-2 antibody titers.
- Antibody responses in COVID-19 patients generally peak within the first 5-6 weeks post-onset.
Introduction:
Among patients with coronavirus disease 2019 (COVID-19), the factors that affect anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody production remain unclear. This study aimed to identify such factors among patients convalescing from COVID-19.
Methods:
This study comprised patients who had been diagnosed with COVID-19 between January 1 and June 30, 2020 and gave consent for anti-SARS-CoV-2 spike protein antibody measurement using enzyme-linked immunosorbent assay during their acute and/or convalescent phases. Factors related to elevated antibody titers and the relationship between the days from disease onset and the development of antibody titers were assessed.
Results:
A total of 84 participants enrolled in the study. Nineteen participants had antibody titers measured during the convalescent phase only, and 65 participants had antibody titers measured during the acute and convalescent phases. The antibody titers peaked in weeks 5 and 6. The stepwise multivariate log-normal analysis revealed that male sex (P = 0.04), diabetes mellitus (P = 0.03), and high C-reactive protein levels during the disease course (P < 0.001) were associated with elevated IgG antibodies. Glucocorticoid use was not associated with antibody titers.
Conclusion:
The study found that high values of maximum CRP levels during the acute phase, male sex, and diabetes mellitus were associated with elevated antibody titers. Antibody titers tended to be highest in the first 5 or 6 weeks after the onset of symptoms.
More Related Videos
Related Concept Videos
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Humoral Immune Responses
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

